S100A8 production in CXCR2-expressing CD11b+Gr-1high cells aggravates hepatitis in mice fed a high-fat and high-cholesterol diet

Journal of Immunology

Volumn 196, Issue 1, 2016, Pages 395-406

  Mukai, Kaori ^a   Miyagi, Takuya ^a   Nishio, Kumiko ^a   Yokoyama, Yoshinobu ^a   Yoshioka, Teppei ^a   Saito, Yoshinobu ^a   Tanaka, Satoshi ^a   Shigekawa, Minoru ^a   Nawa, Takatoshi ^a   Hikita, Hayato ^a   Sakamori, Ryotaro ^a   Yoshihara, Harumasa ^b   Imai, Yasuharu ^c   Hiramatsu, Naoki ^a   Tatsumi, Tomohide ^a   Takehara, Tetsuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA ROSAI HOSPITAL   (Japan)

^c Ikeda Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CD11B ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL1 PROTEIN, MOUSE; DIFFERENTIATION ANTIGEN; GR-1 PROTEIN, MOUSE; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; S100A8 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CYTOLOGY; FEMALE; GENETICS; HEPATITIS; HUMAN; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LIPID DIET; LIVER; LIVER CELL; MALE; METABOLISM; MIDDLE AGED; MOUSE; NONALCOHOLIC FATTY LIVER; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; CALGRANULIN A; CELL LINE; CHEMOKINE CXCL1; DIET, HIGH-FAT; FEMALE; HEPATITIS; HEPATOCYTES; HUMANS; INFLAMMATION; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-8B; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84953217420     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402709     Document Type: Article

References (35)

1. Brunt, E. M. 2005. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Semin. Diagn. Pathol. 22: 330-338.
2. Loomba, R., and A. J. Sanyal. 2013. The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 10: 686-690.
3. Michelotti, G. A., M. V. Machado, and A. M. Diehl. 2013. NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10: 656-665.
4. Wree, A., L. Broderick, A. Canbay, H. M. Hoffman, and A. E. Feldstein. 2013. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat. Rev. Gastroenterol. Hepatol. 10: 627-636.
5. Ehrchen, J. M., C. Sunderkötter, D. Foell, T. Vogl, and J. Roth. 2009. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol. 86: 557-566.
6. Vogl, T., K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, M. A. van Zoelen, W. Nacken, D. Foell, T. van der Poll, C. Sorg, and J. Roth. 2007. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13: 1042-1049.
7. McCormick, M. M., F. Rahimi, Y. V. Bobryshev, K. Gaus, H. Zreiqat, H. Cai, R. S. Lord, and C. L. Geczy. 2005. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J. Biol. Chem. 280: 41521-41529.
8. Sekimoto, R., K. Kishida, H. Nakatsuji, T. Nakagawa, T. Funahashi, and I. Shimomura. 2012. High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice. Biochem. Biophys. Res. Commun. 419: 782-789.
9. Yamaoka, M., N. Mæda, S. Nakamura, T. Mori, K. Inoue, K. Matsuda, R. Sekimoto, S. Kashine, Y. Nakagawa, Y. Tsushima, et al. 2013. Gene expression levels of S100 protein family in blood cells are associated with insulin resistance and inflammation (Peripheral blood S100 mRNAs and metabolic syndrome). Biochem. Biophys. Res. Commun. 433: 450-455.
10. Matsuzawa, N., T. Takamura, S. Kurita, H. Misu, T. Ota, H. Ando, M. Yokoyama, M. Honda, Y. Zen, Y. Nakanuma, et al. 2007. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46: 1392-1403.
11. Kamada, Y., S. Kiso, Y. Yoshida, N. Chatani, T. Kizu, M. Hamano, M. Tsubakio, T. Takemura, H. Ezaki, N. Hayashi, and T. Takehara. 2011. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am. J. Physiol. Gastrointest. Liver Physiol. 301: G1031-G1043.
12. Miyagi, T., T. Takehara, A. Uemura, K. Nishio, S. Shimizu, T. Kodama, H. Hikita, W. Li, A. Sasakawa, T. Tatsumi, et al. 2010. Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet. J. Gastroenterol. 45: 1247-1254.
13. Miyagi, T., T. Takehara, T. Tatsumi, T. Suzuki, M. Jinushi, Y. Kanazawa, N. Hiramatsu, T. Kanto, S. Tsuji, M. Hori, and N. Hayashi. 2004. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver. Hepatology 40: 1190-1196.
14. Miyagi, T., T. Takehara, T. Tatsumi, T. Kanto, T. Suzuki, M. Jinushi, Y. Sugimoto, Y. Sasaki, M. Hori, and N. Hayashi. 2003. CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver. Int. J. Cancer 106: 81-89.
15. Matteoni, C. A., Z. M. Younossi, T. Gramlich, N. Boparai, Y. C. Liu, and A. J. McCullough. 1999. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419.
16. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
17. Murray, P. J., and T. A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11: 723-737.
18. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
19. Ryckman, C., K. Vandal, P. Rouleau, M. Talbot, and P. A. Tessier. 2003. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170: 3233-3242.
20. Wiechert, L., J. Németh, T. Pusterla, C. Bauer, A. De Ponti, S. Manthey, S. Marhenke, A. Vogel, U. Klingmüller, J. Hess, and P. Angel. 2012. Hepatocytespecific S100a8 and S100a9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment. Cell Commun. Signal. 10: 40.
21. Bertola, A., S. Bonnafous, R. Anty, S. Patouraux, M. C. Saint-Paul, A. Iannelli, J. Gugenheim, J. Barr, J. M. Mato, Y. Le Marchand-Brustel, et al. 2010. Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One 5: e13577.
22. Joshi-Barve, S., S. S. Barve, K. Amancherla, L. Gobejishvili, D. Hill, M. Cave, P. Hote, and C. J. McClain. 2007. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46: 823-830.
23. Oppenheim, J. J., C. O. Zachariæ, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9: 617-648.
24. Katoh, H., D. Wang, T. Daikoku, H. Sun, S. K. Dey, and R. N. Dubois. 2013. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 24: 631-644.
25. Ijichi, H., A. Chytil, A. E. Gorska, M. E. Aakre, B. Bierie, M. Tada, D. Mohri, K. Miyabayashi, Y. Asaoka, S. Mæda, et al. 2011. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. J. Clin. Invest. 121: 4106-4117.
26. Stadtmann, A., and A. Zarbock. 2012. CXCR2: From Bench to Bedside. Front. Immunol. 3: 263.
27. Bernhagen, J., R. Krohn, H. Lue, J. L. Gregory, A. Zernecke, R. R. Koenen, M. Dewor, I. Georgiev, A. Schober, L. Leng, et al. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13: 587-596.
28. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
29. Deng, Z. B., Y. Liu, C. Liu, X. Xiang, J. Wang, Z. Cheng, S. V. Shah, S. Zhang, L. Zhang, X. Zhuang, et al. 2009. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 50: 1412-1420.
30. Youn, J. I., M. Collazo, I. N. Shalova, S. K. Biswas, and D. I. Gabrilovich. 2012. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91: 167-181.
31. Edgeworth, J., P. Freemont, and N. Hogg. 1989. Ionomycin-regulated phosphorylation of the myeloid calcium-binding protein p14. Nature 342: 189-192.
32. Mantovani, A., M. A. Cassatella, C. Costantini, and S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11: 519-531.
33. Talukdar, S., Y. Oh, G. Bandyopadhyay, D. Li, J. Xu, J. McNelis, M. Lu, P. Li, Q. Yan, Y. Zhu, et al. 2012. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 18: 1407-1412.
34. Alkhouri, N., G. Morris-Stiff, C. Campbell, R. Lopez, T. A. Tamimi, L. Yerian, N. N. Zein, and A. E. Feldstein. 2012. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 32: 297-302.
35. Rensen, S. S., Y. Slaats, J. Nijhuis, A. Jans, V. Bieghs, A. Driessen, E. Malle, J. W. Greve, and W. A. Buurman. 2009. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am. J. Pathol. 175: 1473-1482.